ARS Pharmaceuticals Stock (NASDAQ: SPRY) stock price, news, charts, stock research, profile.
Open | $8.930 |
Close | $8.740 |
Volume / Avg. | 306.001K / 725.165K |
Day Range | 8.590 - 9.000 |
52 Wk Range | 2.550 - 11.270 |
Market Cap | $846.857M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 11.84% |
Days to Cover | 11.05 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ARS Pharmaceuticals (NASDAQ: SPRY) through any online brokerage.
Other companies in ARS Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Cogent Biosciences (NASDAQ:COGT).
The latest price target for ARS Pharmaceuticals (NASDAQ: SPRY) was reported by Wedbush on Monday, March 11, 2024. The analyst firm set a price target for 19.00 expecting SPRY to rise to within 12 months (a possible 117.39% upside). 9 analyst firms have reported ratings in the last year.
The stock price for ARS Pharmaceuticals (NASDAQ: SPRY) is $8.74 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for ARS Pharmaceuticals.
ARS Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for ARS Pharmaceuticals.
ARS Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.